Constance C. McDaniel Medically Necessary Infant Formula and Donor Milk Act
Legislative Progress
Introduced
May 21, 2026
Latest Action
May 21, 2026
Primary Sponsor
Debbie Wasserman SchultzDemocratic(FL)
Momentum (last 30 days)
2
score
0 actions · 1 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,940 other HR bills in the 119th — cohort avg 30d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2026 · third_quarter · Health Issues
Advocate for issues related to infant formula, including maternal and infant health and paid leave (H.R.5390/S.2823, FAMILY Act), improving affordable access to formula, improving nutrition standards for infants (S.272, Protect Infant Formula from Contamination Act; H.R.7867, Infant Formula Safety Modernization Act), covering formula for women medically unable to breastfeed (H.R.9007, Constance C. McDaniel Medically Necessary Infant Formula and Donor Milk Act), and issues connected to the FDA Commissioner nomination.
Client expense: Not reported · Firm income: $50,000
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Sources: Congress.gov
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Health Issues
Advocate for issues related to infant formula, including maternal health issues (H.R.7973, Momnibus Act), improving affordable access to formula, improving nutrition standards for infants (S.272, Protect Infant Formula from Contamination Act; H.R.7867, Infant Formula Safety Modernization Act), and covering formula for women medically unable to breastfeed (H.R.9007, Constance C. McDaniel Medically Necessary Infant Formula and Donor Milk Act).
Client expense: Not reported · Firm income: $50,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE